Home News & Events Events Workshops Workshops Page tools Share Share Share on LinkedinShare on BlueskyShare on XShare on Facebook Print Search Email Accessibility Workshop Beginners/Intermediate Online NONMEM/PDx-Pop Workshop Date 26 January 2027 - 27 January 2027 Time 09:00 - 17:00 Location Online/Webex Timezone America/New York Workshop Advanced Online NONMEM/PDx-Pop Workshop Date 28 January 2027 Time 09:00 - 17:00 Location Online/Webex Timezone America/New York Workshop NONMEM Intermediate & Advanced Workshop On-site China (Shanghai) Date 9 March 2027 - 11 March 2027 Time 09:00 - 17:00 Location ICON Shanghai Office: 12F, Metropolitan Plaza (都市总部大楼), No. 168 Middle Xizang Road, Huangpu District, Shanghai, China (上海市黄浦区西藏中路168号都市总部大楼12F) Timezone Asia/Shanghai Workshop NONMEM Intermediate & Advanced Workshop On-site China (Beijing) Date 15 March 2027 - 17 March 2027 Time 09:00 - 17:00 Location ICON Beijing Office : 3rd Floor, Building 3, Hongda Industrial Park, No. 8 Hongda North Road, Yizhuang Development Zone, Daxing District, Beijing, 100176, China Timezone Asia/Shanghai In this section In this section Awards Events Industry events ASCO 2026 ISPOR EU 2026 Webinars Workshops In the News Mediakit Facts and figures ICON spokespeople Press releases Social media hub Webinars Connect with us Contact us Submit proposal request Update Email Preferences Global office locator ICON on social media Related information: Event Webinars Event Industry Events What’s happening in ICON ICON Plc As biosimilar regulations evolve, development teams must adapt their analytical strategies to meet changing expectations. In BioProcess International, authors Kimberly Salgado & Radboud van Trigt outline key considerati... 21h View post View webpage ICON Plc Attending #ObesityWeek on Nov 14–17? Meet us as booth \#212 to learn how our comprehensive lab and imaging capabilities support high-quality, large-scale obesity studies. From AI-driven imaging biomarkers to expert guida... 22h View post View webpage ICON Plc ICON has launched the FIRECREST AI-directed video engine, bringing greater speed, scale and consistency to clinical trial communications. Built for regulated environments, the new capability can reduce video production ... 23h View post View webpage ICON Plc Between 2020 and 2024, the FDA has approved a string of first-ever targeted treatments for early-stage chronic conditions, including MASLD, Obesity and Alzheimer's. ICON experts explore the pivotal role that biomarker-ba... 5 Nov View post View webpage ICON Plc Which journals have the biggest impact? We can tell you. PubsHub Journals & Congresses gives you access to over 10,000 options for publishing your work, with 50 important data fields to consider and compare. Fast and eas... 5 Nov View post View webpage ICON Plc Around 600 colleagues from our Chennai office recently came together for the first movie event organised by our India Employee Recreation Club (IERC). Held at PVR Cinemas in Velachery, the event saw colleagues fill two ... 5 Nov View post ICON Plc Meet us at AASLD, booth \#1861 to learn how our deep expertise in imaging-based hepatic biomarkers and global operational support help sponsors optimise trial design and accelerate the delivery of MASH treatments to pati... 4 Nov View post View webpage ICON Plc As clinical development becomes more complex and data-driven, operating models need to evolve to support faster, more confident decision-making. This latest blog explores how FSP, FSO and hybrid approaches can be aligned... 4 Nov View post View webpage ICON Plc Keeping patients engaged across multi-year follow-ups presents a serious hurdle for non-oncology immunotherapy trials. Read our whitepaper to discover how sponsors can curb attrition and support long-term safety monitori... 4 Nov View post View webpage ICON Plc Emerging approaches to first-in-human studies are helping sponsors obtain meaningful clinical insights sooner through integrated study designs, stronger patient engagement, and strategic biomarker implementation. In thi... 4 Nov View post View webpage ICON Plc A cross-functional challenge JCA introduces a common scientific assessment, but evidence expectations can span different populations, comparators, outcomes and national standards of care. A joined-up, cross-functional st... 4 Nov View post View webpage ICON Plc Product arrival isn’t the same as treatment readiness. Before a patient can dose in a cell or gene therapy study, teams may need to verify identity, custody, release, product condition, timing and site readiness. If one ... 3 Nov View post View webpage
